x
Marksman Healthcare
[contact-form-7 id="2459" title="Sidebar Form"]

  • Bulls Stadium, California
  • 666-888-0000
  • info@example.com
Marksman Healthcare
  • Home
  • About Us
  • Services
    • HEOR
    • RWE
    • Value Communications
    • Competitive Intelligence
  • Case studies
  • Publications
  • Key Highlights
  • Blog
  • MarksMan Academy
  • Contact Us
Marksman Healthcare
  • Contact Us
Logo

Contact Info

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • +91-9160467576
  • enquiry@marksmanhealthcare.com

Blogs

    Marksman Healthcare > Blog
Challenges of Single-Arm Trials in NMA

04Sep

Challenges of Single-Arm Trials in Network Meta-Analyses (NMAs)

by MarksMan Healthcare,   0 Comments

Network Meta-Analysis (NMA) is a sophisticated statistical technique that allows researchers to simultaneously compare multiple treatments using a combination of direct and indirect evidence. While NMAs have revolutionized evidence synthesis, […]

Read More
Research Integrity Assessment (RIA) Tool

28Aug

Elevating Evidence Synthesis: Unveiling the Research Integrity Assessment (RIA) Tool

by MarksMan Healthcare,   0 Comments

The bedrock of evidence-based decision-making rests on the integrity of systematic reviews, which rely on the credibility of the studies they encompass. While bias assessment and risk of bias evaluation […]

Read More
Genetic and Genomic Testing in Healthcare

22Aug

Unveiling the Economic Significance of Genomic and Genetic Testing in Healthcare

by MarksMan Healthcare,   0 Comments

In the landscape of modern healthcare, revolutionary advancements are continually reshaping our understanding of genetics and genomics. One such breakthrough that has gained significant attention is genomic and genetic testing. […]

Read More
Matching-Adjusted Indirect Comparison

08Aug

Matching-Adjusted Indirect Comparisons (MAICs): What, Why, and How?

by MarksMan Healthcare,   0 Comments

Meta-analysis is crucial in evidence-based medicine as it combines data from multiple studies for more precise treatment effect estimates. However, when head-to-head clinical trials directly comparing treatments are scarce, Indirect […]

Read More
Hybrid Study Designs

03Aug

Hybrid Study Designs: Combining Existing and New Data for Valuable Insights

by MarksMan Healthcare,   0 Comments

Hybrid study designs are research methodologies that seamlessly blend elements from multiple study designs to address specific research questions comprehensively. Such a hybrid approach allows researchers to capitalize on the […]

Read More
Assessment of Risk of Bias using AI

17Jul

Using AI to Accurately Assess Risk of Bias in Published Articles: Are We There Yet?

by MarksMan Healthcare,   0 Comments

In the realm of medical research, the credibility and accuracy of published articles are paramount. Healthcare professionals rely on these articles to make informed decisions regarding patient care, treatment modalities, […]

Read More
The banner image talks about evaluation of medical devices using RCT and RWD

12Jul

Evaluating Medical Devices: How Do RCT Data and RWD Fit Together?

by MarksMan Healthcare,   0 Comments

Medical devices play a critical role in modern healthcare, aiding in diagnosing, treating, and managing various diseases and conditions. Before these devices are approved for widespread use, they undergo rigorous […]

Read More
The image mentions "Challenges in the Use of Real-World Evidence for Pharmacoeconomic Modeling" which is the topic of the blog

06Jul

Challenges in the Use of Real-World Evidence for Pharmacoeconomic Modeling

by MarksMan Healthcare,   0 Comments

Pharmacoeconomic modeling is vital for healthcare decision-making, enabling stakeholders to evaluate the value and cost-effectiveness of pharmaceutical interventions. These models offer insights into clinical and economic outcomes, aiding policymakers, providers, […]

Read More
External Control Arms (ECA): Optimizing Submissions to HTA Agencies

16Jun

External Control Arms (ECA): Optimizing Submissions to HTA Agencies

by MarksMan Healthcare,   0 Comments

In the realm of pharmaceutical development, the pursuit of safe and effective treatments is paramount. To achieve this, rigorous clinical trials are conducted to evaluate the efficacy and safety of […]

Read More

Posts navigation

1 2 3 4 … 16

Your Partner in Evidence
Synthesis and Market Access

Book Free Sampling Here

Latest Blogs

Quick links

Work with us

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Single Arm Trials in HTA: Navigating Assessment Pathways

December 1, 2023

Generating Regulatory-Grade Real-World Evidence: Tools and Frameworks

November 10, 2023

Using Individual Participant Data for Network Meta-Analysis: Advantages and Challenges

October 19, 2023

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

HEOR, RWE, and Market Access Consulting

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Latest Blogs

Single Arm Trials in HTA: Navigating Assessment Pathways

December 1, 2023

Generating Regulatory-Grade Real-World Evidence: Tools and Frameworks

November 10, 2023

Using Individual Participant Data for Network Meta-Analysis: Advantages and Challenges

October 19, 2023

Quick links

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

Work with us

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

Copyright © 2023 Marksman Healthcare Communications Crafted by LUBUS

 

Loading Comments...